We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Urology

Journal Scan / Research · November 27, 2021

Local Ablative Therapy for Patients With Oligometastatic Prostate Cancer Is Safe and Effective

European Urology Oncology


Additional Info

European Urology Oncology
Toxicity and Efficacy of Local Ablative, Image-guided Radiotherapy in Gallium-68 Prostate-specific Membrane Antigen Targeted Positron Emission Tomography-staged, Castration-sensitive Oligometastatic Prostate Cancer: The OLI-P Phase 2 Clinical Trial
Eur Urol Oncol 2021 Nov 13;[EPub Ahead of Print], T Hölscher, M Baumann, J Kotzerke, K Zöphel, F Paulsen, AC Müller, D Zips, L Koi, C Thomas, S Löck, M Krause, M Wirth, F Lohaus

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Advanced Prostate Cancer Center of Excellence

Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.

Further Reading